MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001)
Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
This study will determine how if MK0782 is safe and tolerable and to determine how often and
the severity of stomach and small intestine ulcers develop following administration of MK0782
plus enteric coated aspirin, rofecoxib 25mg plus enteric coated aspirin, naproxen 500 mg puls
enteric coated asprin vs placebo.
This is an early phase trial and some specific protocol information is in progress and not
publicly available at this time. (Full information is available to trial participants).